BIOCON.NS Cash Flow
Biocon Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-23 21:39
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | N/A | ₹1,176.60 Cr. | ₹1,852.50 Cr. | ₹2,953.90 Cr. | ₹4,061.20 Cr. | ₹1,994.00 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | N/A | ₹-1,699.10 Cr. | ₹-14,281.80 Cr. | ₹-1,004.50 Cr. | ₹-234.10 Cr. | ₹-2,082.10 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | N/A | ₹242.10 Cr. | ₹13,048.70 Cr. | ₹-2,332.70 Cr. | ₹-1,854.00 Cr. | ₹-923.60 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | N/A | ₹3.30 Cr. | ₹21.70 Cr. | ₹2.90 Cr. | ₹31.20 Cr. | ₹199.40 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | N/A | ₹-277.10 Cr. | ₹641.10 Cr. | ₹-380.40 Cr. | ₹2,004.30 Cr. | ₹-812.30 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | N/A | ₹930.80 Cr. | ₹653.70 Cr. | ₹1,299.90 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).